30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Evans Jason Eric

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 57% 68% 82%
Transactions
18 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Evans Jason Eric's trades of Surgery Partners Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-16
S Sale
11,751 -25.6%
89.40
US$4,068,800 		11,751 -25.6% 89.40 US$4,068,800
2026-03-16 2026-03-16
PrS Proposed sale
91,123
350.26
US$4,090,749 		91,123 350.26 US$4,090,749
2026-03-09 2026-03-06
S Sale
24,384 -45.2%
271.44
US$1,743,081 		24,384 -45.2% 271.44 US$1,743,081
2026-03-06 2026-03-06
PrS Proposed sale
11,462
13.79
US$158,100 		11,462 13.79 US$158,100
2025-02-10 2025-02-07
S Sale
26,520 -4.5%
25.65
US$680,238 		26,520 -4.5% 25.65 US$680,238
2025-02-07 2025-02-07
PrS Proposed sale
26,520
25.65
US$680,238 		26,520 25.65 US$680,238
2024-03-13 2024-03-13
PrS Proposed sale
4,840
29.71
US$143,789 		4,840 29.71 US$143,789
2024-03-13 2024-03-13
S Sale
4,840 -1.0%
29.71
US$143,796 		4,840 -1.0% 29.71 US$143,796
2024-03-13 2024-03-11
S Sale
1,984 -0.4%
29.44
US$58,409 		1,984 -0.4% 29.44 US$58,409
2024-03-11 2024-03-11
PrS Proposed sale
1,984
29.44
US$58,415 		1,984 29.44 US$58,415
2024-03-06 2024-03-04
S Sale
9,070 -1.9%
30.61
US$277,633 		9,070 -1.9% 30.61 US$277,633
2024-03-04 2024-03-04
PrS Proposed sale
9,070
30.61
US$277,633 		9,070 30.61 US$277,633
2024-02-14 2024-02-12
S Sale
5,780 -1.4%
35.08
US$202,762 		5,780 -1.4% 35.08 US$202,762
2024-02-12 2024-02-12
PrS Proposed sale
5,780
35.08
US$202,774 		5,780 35.08 US$202,774
2023-12-21 2023-12-19
S Sale
5,000 -1.2%
33.44
US$167,200 		5,000 -1.2% 33.44 US$167,200
2023-07-03 2023-06-29
PlS Planned sale
1,892 -0.4%
45.10
US$85,329 		1,892 -0.4% 45.10 US$85,329
2023-06-29 2023-06-29
PrS Proposed sale
1,892
45.09
US$85,310 		1,892 45.09 US$85,310
2023-04-03 2023-03-31
S Sale
7,674 -1.8%
34.26
US$262,911 		7,674 -1.8% 34.26 US$262,911
2023-03-15 2023-03-15
S Sale
99 -0.0%
30.10
US$2,980 		99 -0.0% 30.10 US$2,980
2023-03-15 2023-03-14
S Sale
12,399 -2.9%
31.10
US$385,609 		12,399 -2.9% 31.10 US$385,609
2023-03-15 2023-03-13
S Sale
10,300 -2.4%
30.11
US$310,133 		10,300 -2.4% 30.11 US$310,133
2023-03-01 2023-02-27
S Sale
20,042 -5.1%
33.53
US$672,008 		20,042 -5.1% 33.53 US$672,008
2023-02-15 2023-02-13
S Sale
5,884 -1.5%
33.90
US$199,468 		5,884 -1.5% 33.90 US$199,468
2022-05-05 2022-05-03
PlS Planned sale
2,042 -0.5%
55.74
US$113,821 		2,042 -0.5% 55.74 US$113,821
2022-04-04 2022-04-01
S Sale
11,467 -2.8%
54.96
US$630,226 		11,467 -2.8% 54.96 US$630,226
2022-03-17 2022-03-15
S Sale
14,065 -3.3%
49.30
US$693,404 		14,065 -3.3% 49.30 US$693,404
2022-03-14 2022-03-11
S Sale
5,061 -1.3%
54.66
US$276,634 		5,061 -1.3% 54.66 US$276,634
2022-03-02 2022-02-28
S Sale
14,071 -3.7%
52.25
US$735,210 		14,071 -3.7% 52.25 US$735,210